Cytomegalovirus Infection Impairs the Nitric Oxide Synthase Pathway: Role of Asymmetric Dimethylarginine in Transplant Arteriosclerosis

Circulation

Volumn 109, Issue 4, 2004, Pages 500-505

  Weis, Michael ^a,b   Kledal, Thomas N ^a   Lin, Ken Y ^a   Panchal, Shyam N ^a   Gao, S Z ^a   Valantine, Hannah A ^a   Mocarski, Edward S ^a   Cooke, John P ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Arteriosclerosis; Endothelium; Transplantation; Viruses

Indexed keywords

ANION; DIMETHYLARGININASE; N(G) METHYLARGININE; N(G),N(G) DIMETHYLARGININE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; SUPEROXIDE;

ADULT; AGED; ALLOGRAFT; ANION TRANSPORT; ARTERIOSCLEROSIS; ARTICLE; CELL DAMAGE; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DISEASE SEVERITY; DNA STRUCTURE; ENDOTHELIUM CELL; ENZYME MECHANISM; ENZYME REGULATION; FEMALE; HEART GRAFT; HEART TRANSPLANTATION; HUMAN; HUMAN CELL; LEUKOCYTE; MALE; MEDIATOR RELEASE; MICROVASCULARIZATION; OXIDATIVE STRESS; PRIORITY JOURNAL; VASCULAR DISEASE; VIRUS ISOLATION;

AMIDOHYDROLASES; ARGININE; CARDIOVASCULAR DISEASES; CELLS, CULTURED; CORONARY ANGIOGRAPHY; CORONARY ARTERIOSCLEROSIS; CYCLIC GMP; CYTOMEGALOVIRUS INFECTIONS; ENDOTHELIUM, VASCULAR; FEMALE; HEART TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; NITRIC OXIDE SYNTHASE; NITRITES; OXIDATIVE STRESS; RISK FACTORS; SIGNAL TRANSDUCTION;

EID: 0842307476     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000109692.16004.AF     Document Type: Article

References (41)

1. Weis M, von Scheidt W. Coronary atherosclerosis in the transplanted heart. Annu Annu Med. 2000;51:81-100.
2. van Dam-Mieras MC, Muller AD, van Hinsbergh VW, et al. The procoagulant response of cytomegalovirus infected endothelial cells. Thromb Haemost. 1992:68:364-370.
3. Span AH, Van Boven CP, Bruggeman CA. The effect of cytomegalovirus infection on the adherence of polymorphonuclear leucocytes to endothelial cells. Eur J Clin Invest. 1989;19:542-548.
4. Shahgasempour S, Woodroffe SB, Garnett HM. Alterations in the expression of ELAM-1, ICAM-1 and VCAM-1 after in vitro infection of endothelial cells with a clinical isolate of human cytomegalovirus. Microbiol Immunol. 1997;41:121-129.
5. Muhlestein JB, Horne BD, Carlquist JF, et al. Cytomegalovirus seropositivity and C-reactive protein have independent and combined predictive value for mortality in patients with angiographically demonstrated coronary artery disease. Circulation. 2000;102:1917-1923.
6. Grattan MT, Moreno-Cabral CE, Starnes VA, et al. Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. JAMA. 1989;261:3561-3566.
7. Valantine HA, Gao SZ, Menon SG, et al. Impact of prophylactic immediate posttransplant ganciclovir on development of transplant atherosclerosis: a post hoc analysis of a randomized, placebo-controlled study. Circulation. 1999;100:61-66.
8. Cooke J, Dzau V. Derangements of the nitric oxide synthase pathway, L-arginine, and cardiovascular disease. Circulation. 1997;96:379-382.
9. Cooke J. Does ADMA cause endothelial dysfunction? Arterioscler Thromb Vasc Biol. 2000;20:2032-2036.
10. Kondo K, Xu J, Mocarski ES. Human cytomegalovirus latency-specific gene expression in granulocyte-macrophage progenitors in culture and in healthy seropositive individuals. Proc Natl Acad Sci USA. 1996;93:11137-11142.
11. Keogh AM, Valantine HA, Hunt SA, et al. Impact of proximal or midvessel discrete coronary artery stenoses on survival after heart transplantation. J Heart Lung Transplant. 1992;11:892-901.
12. St Goar FG, Pinto FJ, Alderman EL, et al. Intracoronary ultrasound in cardiac transplant recipients: in vivo evidence of "angiographically silent" intimal thickening. Circulation. 1992;85:979-987.
13. Waldman WJ, Sneddon JM, Stephens RE, et al. Enhanced endothelial cytopathogenicity induced by a cytomegalovirus strain propagated in endothelial cells. J Med Virol. 1987;28:223-230.
14. Sinzger C, Knapp J, Plachter B, et al. Quantification of replication of clinical cytomegalovirus isolates in cultured endothelial cells and fibroblasts by a focus expansion assay. J Virol Methods. 1997;63:103-112.
15. Stuhlinger MC, Tsao PS, Her JH, et al. Homocysteine impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine. Circulation. 2001;104:2569-2575.
16. Wang H, Joseph JA. Quantifying cellular oxidative stress by dichlorfluorescein assay using microplate reader. Free Radic Biol Med. 1999;27:612-616.
17. Billstrom Schroeder M, Worthen GS. Viral regulation of RANTES expression during human cytomegalovirus infection of endothelial cells. J Virol. 2001;75:3383-3390.
18. Levi M. CMV endothelitis as a factor in the pathogenesis of atherosclerosis. Cardiovasc Res. 2001;50:432-433.
19. Burns LJ, Pooley JC, Walsh DJ, et al. Intercellular adhesion molecule-1 expression in endothelial cells is activated by cytomegalovirus immediate early proteins. Transplantation. 1999;67:137-144.
20. Waldman WJ, Knight DA, Huang EH. An in vitro model of T cell activation by autologous cytomegalovirus (CMV)-infected human adult endothelial cells: contribution of CMV-enhanced endothelial ICAM-1. J Immunol. 1998;160:3143-3151.
21. Span AH, van Dam-Mieras MC, Mullers W et al. The effect of virus infection on the adherence of leukocytes or platelets to endothelial cells. Eur J Clin Invest. 1991;21:331-338.
22. Pampou S, Gnedoy SN, Bystrevskaya VB, et al. Cytomegalovirus genome and the immediate-early antigen in cells of different layers of human aorta. Virchows Arch. 2000;436:539-552.
23. Knight DA, Waldman WJ, Sedmak DD. Cytomegalovirus-mediated modulation of adhesion molecule expression by human arterial and microvascular endothelial cells. Transplantation. 1999;68:1814-1818.
24. Froberg MK, Adams A, Seacotte N, et al. Cytomegalovirus infection accelerates inflammation in vascular tissue overexpressing monocyte chemoattractant protein-1. Circ Res. 2001;89:1224-1230.
25. Horvath R, Cerny J, Benedik JJ, et al. The possible role of human cytomegalovirus (HCMV) in the origin of atherosclerosis. J Clin Virol. 2000;16:17-24.
26. Vallance P. Importance of asymmetrical dimethylarginine in cardiovascular risk. Lancet. 2001;358:2096-2097.
27. Ogawa T, Kimoto M, Sasaoka K. Purification and properties of a new enzyme, NG, NG-dimethylarginine dimethylaminohydrolase, from rat kidney. J Biol Chem. 1989;264:10205-10209.
28. Leiper JM, Santa Maria J, Chubb A et al. Identification of two human dimethylarginine dimethylaminohydrolases with distinct tissue distributions and homology with microbial arginine deiminases. Biochem J. 1999;343:209-214.
29. Ito A, Tsao PS, Adimoolam S, et al. Novel mechanism for endothelial dysfunction: dysregulation of dimethylarginine dimethylaminohydrolase. Circulation. 1999;99:3092-3095.
30. Leiper J, Murray-Rust J, McDonald N et al. S-nitrosylation of dimethylarginine dimethylaminohydrolase regulates enzyme activity: further interactions between nitric oxide synthase and dimethylarginine dimethylaminohydrolase. Proc Natl Acad Sci U S A. 2002;99:13527-13532.
31. Beltran B, Orsi A, Clementi E, et al. Oxidative stress and S-nitrosylation of proteins in cells. Br J Pharmacol. 2000;129:953-960.
32. Waldman WJ, Knight DA. Cytokine-mediated induction of endothelial adhesion molecule and histocompatibility leukocyte antigen expression by cytomegalovirus-activated T cells. Am J Pathol. 1996;148:105-119.
33. Koide M, Kawahara Y, Tsuda T, et al. Cytokine-induced expression of an inducible type of nitric oxide synthase gene in cultured vascular smooth muscle cells. FEBS Lett. 1993;318:213-217.
34. Xia Y, Zweier JL. Superoxide and peroxynitrite generation from inducible nitric oxide synthase in macrophages. Proc Natl Acad Sci USA. 1997;94:6954-6958.
35. Boger R, Bode-Boger S, Tsao P, et al. An endogenous inhibitor of nitric oxide synthase regulates endothelial adhesiveness for monocytes. J Am Coll Cardiol. 2000;36:2287-2295.
36. Drexler H, Fischell TA, Pinto FJ, et al. Effect of L-arginine on coronary endothelial function in cardiac transplant recipients: relation to vessel wall morphology. Circulation. 1994;89:1615-1623.
37. Cooke JP, Dzau VJ. Nitric oxide synthase: role in the genesis of vascular disease. Annu Rev Med. 1997;48:489-509.
38. Cayatte AJ, Palacino JJ, Horten K, et al. Chronic inhibition of nitric oxide production accelerates neointima formation and impairs endothelial function in hypercholesterolemic rabbits. Arterioscler Thromb. 1994;14:753-759.
39. Huang PL. Disruption of the endothelial nitric oxide synthase gene: effect on vascular response to injury. Am J Cardiol. 1998;82:57S-59S.
40. Cooke J, Singer A, Tsao. Anti-atherogeneic effects of L-arginine in the hypercholesterolemic rabbit. J Clin Invest. 1992;90:1168-1172.
41. von der Leyen HE, Gibbons GH, Morishita R, et al. Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene. Proc Natl Acad Sci U S A. 1995;92:1137-1141.